Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Cao

Showing results (421-430 of 461) with videos related to

Pageof 47
Sort By:
Current Oncology (Toronto, Ont.)|November 26, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast CancerJeffrey Q Cao, Brae Surgeoner, Mita Manna, et al.
Genomics|March 15, 2001
Genetic diversity of the human serotonin receptor 1B (HTR1B) geneA R Sanders, Q Cao, J Taylor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2025
A critical review of randomized controlled trials on topical corticosteroids for the prevention of radiation dermatitis in breast cancerOlivia Kuszaj, Marley Day, Shirley S W Tse, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 19, 2024
[Clinical features and follow-up study on 55 patients with adolescence-onset methylmalonic acidemia]X Ma, Z H Chen, H T Zhang, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Aalok Kumar, Katarzyna J Jerzak, Karen A Gelmon, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025Sandeep Sehdev, Anil Abraham Joy, Jean-François Boileau, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic SettingMita Manna, Karen A Gelmon, Jean-François Boileau, et al.
Leukemia|March 11, 2005
Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countriesB Chen, W-L Zhao, J Jin, et al.
NPJ Precision Oncology|August 16, 2022
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclibZhou Zhu, Nicholas C Turner, Sherene Loi, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 14, 2022
[Relationship between treatment and prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation]L Q Cao, J R Zhou, Y H Chen, et al.
Pageof 47

Showing results (421-430 of 461) with videos related to

Sort By:
Pageof 47
Current Oncology (Toronto, Ont.)|November 26, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast CancerJeffrey Q Cao, Brae Surgeoner, Mita Manna, et al.
Genomics|March 15, 2001
Genetic diversity of the human serotonin receptor 1B (HTR1B) geneA R Sanders, Q Cao, J Taylor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2025
A critical review of randomized controlled trials on topical corticosteroids for the prevention of radiation dermatitis in breast cancerOlivia Kuszaj, Marley Day, Shirley S W Tse, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 19, 2024
[Clinical features and follow-up study on 55 patients with adolescence-onset methylmalonic acidemia]X Ma, Z H Chen, H T Zhang, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Aalok Kumar, Katarzyna J Jerzak, Karen A Gelmon, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025Sandeep Sehdev, Anil Abraham Joy, Jean-François Boileau, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic SettingMita Manna, Karen A Gelmon, Jean-François Boileau, et al.
Leukemia|March 11, 2005
Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countriesB Chen, W-L Zhao, J Jin, et al.
NPJ Precision Oncology|August 16, 2022
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclibZhou Zhu, Nicholas C Turner, Sherene Loi, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 14, 2022
[Relationship between treatment and prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation]L Q Cao, J R Zhou, Y H Chen, et al.
Pageof 47